Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-13

Clinical Trial Update: Speech-derived Digital Biomarkers Study [NA]

View source ↗

Summary

A completed clinical trial investigating speech-derived digital biomarkers in individuals with mild cognitive impairment and Alzheimer's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Hackensack Meridian Health | Conditions: Mild Cognitive Impairment (MCI), Alzheimer Disease | NA | Status: COMPLETED